Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.074 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |